Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » Item 3.02 Unregistered Sales of Equity Securities.

This excerpt taken from the EYE 8-K filed Nov 22, 2005.

Item 3.02 Unregistered Sales of Equity Securities.

On November 17, 2005, Advanced Medical Optics, Inc. issued an aggregate of 161,742 shares of its common stock to a holder of its 3½% Convertible Senior Subordinated Notes due 2023 (the “3½% convertible notes”) in exchange for $3,000,000 aggregate principal amount of the 3½% convertible notes in a privately negotiated transaction. The issuance of the shares of common stock was made in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended.

 

 

1

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 22, 2005

ADVANCED MEDICAL OPTICS, INC.
(Registrant)

 

 

By: /s/ Aimee Weisner                                

 

Aimee S. Weisner

 

 

Corporate Vice President
General Counsel and Secretary

 
This excerpt taken from the EYE 8-K filed Jul 19, 2005.

Item 3.02 Unregistered Sales of Equity Securities.

 

See disclosure under Item 1.01 of this Report, which is incorporated by reference in this Item 3.02.

 

This excerpt taken from the EYE 8-K filed Apr 18, 2005.

Item 3.02     Unregistered Sales of Equity Securities.


                On April 14, 2005, Advanced Medical Optics, Inc. issued an aggregate of 160,695 shares of its common stock to a holder of its 3½% Convertible Senior Subordinated Notes due 2023 (the “3½% convertible notes”) in exchange for $3,000,000 aggregate principal amount of the 3½% convertible notes in a privately negotiated transaction. The issuance of the shares of common stock was made in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended.


SIGNATURES


                Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ADVANCED MEDICAL OPTICS, INC.
(Registrant)

Date:     April 18, 2005   By:  /s/ Aimee S. Weisner
       
    Aimee S. Weisner
Corporate Vice President,
General Counsel and Secretary 

EXCERPTS ON THIS PAGE:

8-K
Nov 22, 2005
8-K
Jul 19, 2005
8-K
Apr 18, 2005

RELATED TOPICS for EYE:

"Item 3.02 Unregistered Sales of Equity Securities." elsewhere:

ABIOMED (ABMD)
Antares Pharma (AIS)
Alphatec Holdings (ATEC)
AtriCure (ATRC)
Conceptus (CPTS)
STAAR Surgical Company (STAA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki